Product, People, Potential

We caught up with Caroline Barelle, the CEO of Elasmogen, as part of ‘Product | People | Potential’. Elasmogen is progressing next generation biologics for…

We caught up with Carolyn Porter, CEO at CytoSeek. CytoSeek is enabling the next generation of cell therapies through its artificial membrane-binding protein technology. The…

We caught up with Guillem Singla, CEO and Co-Founder of Neurofenix as part of ‘Product | People | Potential’. Neurofenix are working on engaging stroke…

We caught up with Neciah Dorh, CEO and Founder of FluoretiQ. FluoretiQ is a rapid bacterial identification technology that can diagnose infection within minutes, leading…

We caught up with Adrian Shedden, Co-Founder of Lumio. Lumio is the next generation of personal finance. With all your accounts in one place. The…

We caught up with Konstantina Psoma, Co-founder & CEO at Kaedim, as part of ‘Product | People | Potential’. Kaedim is a platform that makes…

We caught up with Gustaf Hemberg, Co-Founder & CEO of Scindo as part of ‘Product | People | Potential’. Scindo is creating a novel biological…

We caught up with Katie Critchlow, CEO of NatureMetrics, as part of ‘Product | People | Potential’. NatureMetrics use next generation sequencing to identify species…

We caught up with Yosi Romano, CEO and Co-Founder of Brizi. Brizi protects babies from the harmful effects of air pollution and informs the community…

We caught up with Orr Yarkoni, CEO of Colorifix, as part of ‘Product | People | Potential’. Colorifix uses synthetic biology to remove the need…

We caught up with Joe Bloxsome, Aled Davies and Matthew White, Co-Founders of Codeherent. Codeherent is a start-up based in South Wales helping businesses to…

We caught up with Clarissa Sowemimo-Coker, General Counsel at Oxford Cannabinoid Technologies, and Valentino Parravicini, the Chief Scientific Officer. Oxford Cannabinoid Technologies is a biopharmaceutical…